|
|
||||||||
|
FJ
EXPRESS SUMMARY ARTICLE The Full-length version of this article is also available, published online March 4, 2004 as doi:10.1096/fj.03-0446fje. |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







* Max Delbrück Center for Molecular Medicine, Berlin, Germany;
Franz Volhard Clinic, Humboldt University (Charité), Berlin, Germany;
Institute of Theoretical and Experimental Biophysics, Academy of Sciences of Russia, Pushchino, Russia;
Max Planck Inst. for Physiological and Clinical Research, Bad Nauheim, Germany; and

Johannes Müller Institute for Physiology, Humboldt University (Charité), Berlin, Germany
2Correspondence: Max Delbrück Center for Molecular Medicine, 13092 Berlin, Germany, E-mail: haase{at}mdc-berlin.de
SPECIFIC AIMS
Ahnak is encoded by an intronless gene located on human chromosome 11q12. It has been implicated in fundamental cellular processes as diverse as cell differentiation, signal transduction, and regulated exocytosis. However, no information is available about the existence of ahnak isoforms that serve different cell type-specific functions. In cardiomyocytes we identified ahnak as a 700 kDa protein that localized to the inner side of the sarcolemma membrane and interacted with the ß subunit of the L-type Ca2+ channel and with F-actin via its carboxyl-terminal domain (ahnak-C2) of 382 amino acids. The aim of the present study was to elucidate a potential functional role of ahnak-C2 on actin filaments. We searched for putative ahnak isoforms by subdomain-specific antibodies.
PRINCIPAL FINDINGS
1. Identification of a cardiac-specific, carboxyl-terminal ahnak fragment
A domain-specific anti-ahnak antibody was generated against the carboxyl-terminal amino acid residues (56115624) of human ahnak. This antibody, designated as Tail-Ab, differed in immunorecognition pattern from the established ahnak antibody, KIS-Ab. KIS-Ab reacted strongly with the 700 kDa ahnak protein in rat heart and skeletal muscle whereas Tail-Ab barely reacted with the full-length protein in both muscle types. Moreover, the Tail-Ab detected a putative carboxyl-terminal ahnak fragment in cardiac but not in the skeletal muscle. Immunocytochemistry of rat heart revealed Tail-Ab labeling as regularly spaced intracellular striations in longitudinal sections of cardiomyocytes (Fig. 1
A). This labeling pattern was different from that of the KIS-Ab, which showed plasma membrane labeling in sections of the same tissue block (Fig. 1B
). Clear plasma membrane labeling and no intracellular staining were obtained by Tail-Ab (Fig. 1C
) and KIS-Ab (Fig. 1D
) in rat skeletal muscle under the same experimental conditions. The ahnak antibodies revealed comparable subcellular location in skeletal muscle in which the carboxyl-terminal ahnak fragment was not observed.
|
Human cardiac preparations were used for further expression and localization studies. In normal human heart, the Tail-Ab reacted strongly with a protein of 72 ± 3 kDa (n=5). This protein was also identified by the ahnak-C2 antibody after epitope splitting. This ahnak fragment copurified with the myofibrillar protein fraction. The subcellular distribution of the 72 kDa carboxyl-terminal ahnak fragment was studied by immunofluorescence microscopy in double labeling experiments with the sarcomeric Z-band- and M-band proteins
-actinin and myomesin, respectively. Confocal imaging of longitudinal sections of normal human myocardium revealed labeling of ahnaks Tail-Ab epitope in regular cross-striations (Fig. 2
A). A similar picture was obtained for
-actinin in its typical regular cross-striated pattern at the level of the Z-line (Fig. 2B
). The intercalated disc was also stained by the Tail-Ab (Fig. 2A
, arrow). Merged images indicate remarkable colocalization of ahnaks Tail-Ab epitope and
-actinin at both the Z-line and the intercalated disc (Fig. 2C
). The images in the lower panel of Fig. 2
compare the location of ahnaks Tail-Ab epitope with myomesin. Again, the regular cross-striated pattern was clearly obtained with the Tail-Ab (Fig. 2D
) and, as expected for myomesin, at the M-band of the sarcomere (Fig. 2E
). Merged images of both proteins revealed a clear alternate staining pattern for ahnaks Tail-Ab epitope and myomesin (Fig. 2F
).
|
2. Ahnak-C2 binds to skeletal muscle fibers and stabilizes their contractility
We used recombinant ahnak-C2 for functional studies with demembraned skeletal muscle fibers. Isometric force development of demembraned skeletal muscle fibers (M. gastrocnemius) was monitored at submaximal (pCa 5.8) and at maximal (pCa 5.0) Ca2+ activation during two subsequent contraction/relaxation cycles. The isometric force development under control conditions at pCa 5.0 was 1.81 ± 0.33 mN (n=8). When isometric force development of the first contraction cycle was compared with that of the second contraction cycle, we observed a significant decrease in force development at submaximal and maximal Ca2+ activation. Addition of GST-ahnak-C2 to the fibers attenuated this decline of force during the second contraction/relaxation cycle significantly: isometric force development at submaximal Ca2+ activation declined to 43.8 ± 4.8% in the presence of 1 µM GST-ahnak-C2, and force development at maximal Ca2+ activation (pCa 5.0) could be maintained at the level of the first contraction/relaxation cycle. During this protocol, skinned skeletal muscle fibers bound ahnak-C2 as assessed by immunoblotting.
3. Ahnak-C2 has actin bundling activity
Actin filaments were incubated with recombinant ahnak-C2 and inspected by electron microscopy. GST-ahnak-C2 induced different stages of actin filament bundling ranging from loose bundles to tight packing into paracrystalline-like structures. The thickness of bundles was up to 250 nm (Fig. 3
A). No actin bundling was observed with unfused GST (Fig. 3B
).
|
CONCLUSIONS AND SIGNIFICANCE
The findings presented in this study substantially contribute to our understanding of the role of ahnak in cardiomyocytes. Our results suggest that ahnak interacts with actin at specific sites: full-length ahnak anchors sarcolemma proteins (e.g., L-type Ca2+ channels) to the subsarcolemmal actin-based cytoskeleton whereas the cardiac-specific carboxyl-terminal ahnak fragment accumulates at the level of Z-lines and intercalated discs for interaction with myofibrillar F-actin. Both myofibrillar Z-line structures and intercalated discs play a crucial role in the establishment and maintenance of cardiomyocyte cytoarchitecture and contractile function.
FOOTNOTES
1 To read the full text of this article, go to http://www.fasebj.org/cgi/doi/10.1096/fj.03-0446fje; ![]()
This article has been cited by other articles:
![]() |
Y. Huang, A. de Morree, A. van Remoortere, K. Bushby, R. R. Frants, J. T. Dunnen, and S. M. van der Maarel Calpain 3 is a modulator of the dysferlin protein complex in skeletal muscle Hum. Mol. Genet., June 15, 2008; 17(12): 1855 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Parikh, E. Nilsson, C. Ling, P. Poulsen, P. Almgren, H. Nittby, K.-F. Eriksson, A. Vaag, and L. C. Groop Molecular correlates for maximal oxygen uptake and type 1 fibers Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1152 - E1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Haase Ahnak, a new player in {beta}-adrenergic regulation of the cardiac L-type Ca2+ channel Cardiovasc Res, January 1, 2007; 73(1): 19 - 25. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Haase, J. Alvarez, D. Petzhold, A. Doller, J. Behlke, J. Erdmann, R. Hetzer, V. Regitz-Zagrosek, G. Vassort, and I. Morano Ahnak is critical for cardiac Ca(v)1.2 calcium channel function and its {beta}-adrenergic regulation FASEB J, December 1, 2005; 19(14): 1969 - 1977. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |